These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31762174)

  • 1. Long-term effects of Na
    Primessnig U; Bracic T; Levijoki J; Otsomaa L; Pollesello P; Falcke M; Pieske B; Heinzel FR
    Eur J Heart Fail; 2019 Dec; 21(12):1543-1552. PubMed ID: 31762174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction.
    Primessnig U; Schönleitner P; Höll A; Pfeiffer S; Bracic T; Rau T; Kapl M; Stojakovic T; Glasnov T; Leineweber K; Wakula P; Antoons G; Pieske B; Heinzel FR
    Eur J Heart Fail; 2016 Aug; 18(8):987-97. PubMed ID: 27135883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ entry mode of Na+/Ca2+ exchanger as a new therapeutic target for heart failure with preserved ejection fraction.
    Kamimura D; Ohtani T; Sakata Y; Mano T; Takeda Y; Tamaki S; Omori Y; Tsukamoto Y; Furutani K; Komiyama Y; Yoshika M; Takahashi H; Matsuda T; Baba A; Umemura S; Miwa T; Komuro I; Yamamoto K
    Eur Heart J; 2012 Jun; 33(11):1408-16. PubMed ID: 21490055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction.
    Rouhana S; Farah C; Roy J; Finan A; Rodrigues de Araujo G; Bideaux P; Scheuermann V; Saliba Y; Reboul C; Cazorla O; Aimond F; Richard S; Thireau J; Fares N
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):230-242. PubMed ID: 30463691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na
    Bai XJ; Hao JT; Wang J; Zhang WF; Yan CP; Zhao JH; Zhao ZQ
    Pharmacol Rep; 2018 Feb; 70(1):60-68. PubMed ID: 29331788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular dyssynchrony of diastolic cytosolic [Ca²⁺] decay in ventricular cardiomyocytes in cardiac remodeling and human heart failure.
    Hohendanner F; Ljubojević S; MacQuaide N; Sacherer M; Sedej S; Biesmans L; Wakula P; Platzer D; Sokolow S; Herchuelz A; Antoons G; Sipido K; Pieske B; Heinzel FR
    Circ Res; 2013 Aug; 113(5):527-38. PubMed ID: 23825358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficiency of Na+/Ca2+ exchanger or Na+/H+ exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias.
    Szepesi J; Acsai K; Sebok Z; Prorok J; Pollesello P; Levijoki J; Papp JG; Varro A; Toth A
    J Physiol Pharmacol; 2015 Apr; 66(2):215-26. PubMed ID: 25903952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Na(+)/Ca(2+) exchanger and L-type calcium channel block as a potential strategy to suppress arrhythmias and maintain ventricular function.
    Bourgonje VJ; Vos MA; Ozdemir S; Doisne N; Acsai K; Varro A; Sztojkov-Ivanov A; Zupko I; Rauch E; Kattner L; Bito V; Houtman M; van der Nagel R; Beekman JD; van Veen TA; Sipido KR; Antoons G
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):371-9. PubMed ID: 23515266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
    Hohendanner F; Bode D; Primessnig U; Guthof T; Doerr R; Jeuthe S; Reimers S; Zhang K; Bach D; Wakula P; Pieske BM; Heinzel FR
    J Mol Cell Cardiol; 2018 Feb; 115():10-19. PubMed ID: 29289652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF.
    Bode D; Semmler L; Wakula P; Hegemann N; Primessnig U; Beindorff N; Powell D; Dahmen R; Ruetten H; Oeing C; Alogna A; Messroghli D; Pieske BM; Heinzel FR; Hohendanner F
    Cardiovasc Diabetol; 2021 Jan; 20(1):7. PubMed ID: 33413413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right-ventricular dysfunction in HFpEF is linked to altered cardiomyocyte Ca
    Hegemann N; Primessnig U; Bode D; Wakula P; Beindorff N; Klopfleisch R; Michalick L; Grune J; Hohendanner F; Messroghli D; Pieske B; Kuebler WM; Heinzel FR
    ESC Heart Fail; 2021 Aug; 8(4):3130-3144. PubMed ID: 34002482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic effect of NCX inhibition depends on the relative activity of the reverse NCX assessed by a novel inhibitor ORM-10962 on canine ventricular myocytes.
    Oravecz K; Kormos A; Gruber A; Márton Z; Kohajda Z; Mirzaei L; Jost N; Levijoki J; Pollesello P; Koskelainen T; Otsomaa L; Tóth A; Papp JG; Nánási PP; Antoons G; Varró A; Acsai K; Nagy N
    Eur J Pharmacol; 2018 Jan; 818():278-286. PubMed ID: 29066415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
    Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction.
    De Angelis A; Cappetta D; Piegari E; Rinaldi B; Ciuffreda LP; Esposito G; Ferraiolo FA; Rivellino A; Russo R; Donniacuo M; Rossi F; Urbanek K; Berrino L
    Int J Cardiol; 2016 Aug; 217():69-79. PubMed ID: 27179211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
    Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T
    Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments.
    Kohajda Z; Farkas-Morvay N; Jost N; Nagy N; Geramipour A; Horváth A; Varga RS; Hornyik T; Corici C; Acsai K; Horváth B; Prorok J; Ördög B; Déri S; Tóth D; Levijoki J; Pollesello P; Koskelainen T; Otsomaa L; Tóth A; Baczkó I; Leprán I; Nánási PP; Papp JG; Varró A; Virág L
    PLoS One; 2016; 11(11):e0166041. PubMed ID: 27832106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.